Discovery of an inhibitor of DNA-driven inflammation that preferentially targets the AIM2 inflammasome

Related articles

1. TH5487 specifically targets NLRP3 in FCAS patients resistant to MCC950

   This article has 13 authors:

   1. Angela Lackner
   2. Lemuel Leonidas
   3. Alijah Macapagal
   4. Hannah Lee
   5. Huilin Xu
   6. Yanfei Qiu
   7. Melissa Campos
   8. Julia E. Cabral
   9. Janset Onyuru
   10. Sanika Kulkarni
   11. Lauren V. Albrecht
   12. Hal M. Hoffman
   13. Reginald McNulty

2. Inhibition of NLRP3 by a CNS-penetrating indazole scaffold

   This article has 18 authors:

   1. Jane Torp
   2. Dominic Ferber
   3. Hannes Buthmann
   4. Gregor Hagelueken
   5. Aditi Deshpande
   6. George Hartman
   7. Robert E. Hughes
   8. Taiz Salazar
   9. Sarah Tronnes
   10. Assem Duisembekova
   11. Michael Marleaux
   12. Inga V. Hochheiser
   13. Rebecca C. Coll
   14. Rusty Montgomery
   15. Kristen Fortney
   16. Bénédicte F. Py
   17. Kevin Wilhelmsen
   18. Matthias Geyer

3. Activity-based probes and chemical proteomics uncover the biological impact of targeting HMGCS1

   This article has 6 authors:

   1. Sang Ah Yi
   2. Liang Sun
   3. Yi Rao
   4. Alban Ordureau
   5. Jason S. Lewis
   6. Heeseon An